Evidence map›Paper›PMID 27117030›Full record

ArticleFree radical biology & medicine2016

Glutathione reductase gsr-1 is an essential gene required for Caenorhabditis elegans early embryonic development.

José Antonio Mora-Lorca, Beatriz Sáenz-Narciso, Christopher J Gaffney, Francisco José Naranjo-Galindo, José Rafael Pedrajas, David Guerrero-Gómez, Agnieszka Dobrzynska, Peter Askjaer, Nathaniel J Szewczyk, Juan Cabello and 1 more

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

José Antonio Mora-LorcaInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
Beatriz Sáenz-NarcisoCenter for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain.
Christopher J GaffneyMRC/ARUK Centre for Musculoskeletal Ageing Research, University of Nottingham and Medical School Royal Derby Hospital, DE22 3DT Derby, United Kingdom.
Francisco José Naranjo-GalindoInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
José Rafael PedrajasGrupo de Bioquímica y Señalización Celular, Departamento de Biología Experimental, Universidad de Jaén, 23071 Jaén, Spain.
David Guerrero-GómezInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
Agnieszka DobrzynskaAndalusian Center for Developmental Biology (CABD), CSIC/JA/Universidad Pablo de Olavide, 41013 Seville, Spain.
Peter AskjaerAndalusian Center for Developmental Biology (CABD), CSIC/JA/Universidad Pablo de Olavide, 41013 Seville, Spain.
Nathaniel J SzewczykMRC/ARUK Centre for Musculoskeletal Ageing Research, University of Nottingham and Medical School Royal Derby Hospital, DE22 3DT Derby, United Kingdom.
Juan CabelloCenter for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain. Electronic address: juan.cabello@riojasalud.es.
Antonio Miranda-VizueteInstituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain. Electronic address: amiranda-ibis@us.es.
Center for Biomedical Research of La Rioja · ESUniversidad de Sevilla · ESCentro Andaluz de Biología del Desarrollo · ESHospital Universitario Virgen del Rocío · ESInstituto de Biomedicina de Sevilla · ESRoyal Derby Hospital · GBUniversidad de Jaén · ESUniversidad Pablo de Olavide · ESUniversity of Nottingham · GB

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Gene Networks Regulating Muscle Protein DegradationR01AR054342 · NIAMS · UNIVERSITY OF NOTTINGHAM · PI SZEWCZYK, NATHANIEL J. · 2007 to 2010
$902k
NIAMS NIH HHS R01 AR054342NIH HHS P40 OD010440
6 · The paper itself

Abstract

Glutathione is the most abundant thiol in the vast majority of organisms and is maintained in its reduced form by the flavoenzyme glutathione reductase. In this work, we describe the genetic and functional analysis of the Caenorhabditis elegans gsr-1 gene that encodes the only glutathione reductase protein in this model organism. By using green fluorescent protein reporters we demonstrate that gsr-1 produces two GSR-1 isoforms, one located in the cytoplasm and one in the mitochondria. gsr-1 loss of function mutants display a fully penetrant embryonic lethal phenotype characterized by a progressive and robust cell division delay accompanied by an aberrant distribution of interphasic chromatin in the periphery of the cell nucleus. Maternally expressed GSR-1 is sufficient to support embryonic development but these animals are short-lived, sensitized to chemical stress, have increased mitochondrial fragmentation and lower mitochondrial DNA content. Furthermore, the embryonic lethality of gsr-1 worms is prevented by restoring GSR-1 activity in the cytoplasm but not in mitochondria. Given the fact that the thioredoxin redox systems are dispensable in C. elegans, our data support a prominent role of the glutathione reductase/glutathione pathway in maintaining redox homeostasis in the nematode.

Indexed as

AnimalsCaenorhabditis elegansCytoplasmEmbryonic DevelopmentGenes, EssentialGlutathioneGlutathione ReductaseMitochondriaMutant ProteinsOxidation-ReductionProtein IsoformsThioredoxinsGlutathioneGlutathione ReductaseMutant ProteinsProtein IsoformsThioredoxinsCaenorhabditis elegansEmbryonic developmentGlutathione reductaseMitochondriaRedox

Identifiers

PMID27117030
PMCPMC8386055
OpenAlexW2344957984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.